title: Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.
abstract: Highly pathogenic influenza H5N1 virus continues to pose a threat to public health. Although the mechanisms underlying the pathogenesis of the H5N1 virus have not been fully defined, it has been suggested that cytokine dysregulation plays an important role. As the human respiratory epithelium is the primary target cell for influenza viruses, elucidating the viral tropism and innate immune responses of influenza H5N1 virus in the alveolar epithelium may help us to understand the pathogenesis of the severe pneumonia associated with H5N1 disease. Here we used primary cultures of differentiated human alveolar type II cells, alveolar type I-like cells, and alveolar macrophages isolated from the same individual to investigate viral replication competence and host innate immune responses to influenza H5N1 (A/HK/483/97) and H1N1 (A/HK/54/98) virus infection. The viral replication kinetics and cytokine and chemokine responses were compared by quantitative PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA). We demonstrated that influenza H1N1 and H5N1 viruses replicated productively in type II cells and type I-like cells although with different kinetics. The H5N1 virus replicated productively in alveolar macrophages, whereas the H1N1 virus led to an abortive infection. The H5N1 virus was a more potent inducer of proinflammatory cytokines and chemokines than the H1N1 virus in all cell types. However, higher levels of cytokine expression were observed for peripheral blood monocyte-derived macrophages than for alveolar macrophages in response to H5N1 virus infection. Our findings provide important insights into the viral tropisms and host responses of different cell types found in the lung and are relevant to an understanding of the pathogenesis of severe human influenza disease.
authors.affiliation: Department of Microbiology, the University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.
authors.forename: Wendy C L
authors.initials: WC
authors.lastname: Yu
authors.forename: Renee W Y
authors.initials: RW
authors.lastname: Chan
authors.forename: Jieru
authors.initials: J
authors.lastname: Wang
authors.forename: Emily A
authors.initials: EA
authors.lastname: Travanty
authors.forename: John M
authors.initials: JM
authors.lastname: Nicholls
authors.forename: J S Malik
authors.initials: JS
authors.lastname: Peiris
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Mason
authors.forename: Michael C W
authors.initials: MC
authors.lastname: Chan
mesh_terms: D002454:Cell Differentiation; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay; D004847:Epithelial Cells / Q000821:virology; D006801:Humans; D007113:Immunity, Innate; D053118:Influenza A Virus, H1N1 Subtype / Q000502:physiology*; D053124:Influenza A Virus, H5N1 Subtype / Q000502:physiology*; D016676:Macrophages, Alveolar / Q000276:immunology / Q000821:virology*; D016133:Polymerase Chain Reaction; D011650:Pulmonary Alveoli / Q000166:cytology / Q000276:immunology / Q000821:virology*; D014779:Virus Replication